A quick guide to U.S. and global operations

Key Facts

A quick guide to U.S. and global operations.

Overview:

Daiichi Sankyo, Inc., is the U.S. headquarters of Tokyo-based DAIICHI SANKYO, COMPANY, LTD. Daiichi Sankyo, Inc. is a member of the Daiichi Sankyo Group, which spans 56 countries. Click here to download an easy-to-read company overview.

Established:

Daiichi Sankyo, Inc.  was established in 2006 from the merger of the Daiichi and Sankyo pharmaceutical companies.

Industry:

Pharmaceuticals

Concentration:

We currently market therapies in hypertension, dyslipidemia, diabetes, acute coronary syndrome and metastatic melanoma.

U.S. Headquarters:

Daiichi Sankyo, Inc.
Two Hilton Court
Parsippany, NJ 07054
Phone: 973-944-2600

U.S. Employees:

Approximately 2,500 including Daiichi Sankyo Pharma Development

FY 2012 Net Sales:

$1.7 Billion

Global Clinical Development:

Daiichi Sankyo Pharma Development
399 Thornall Street
Edison, NJ 08837
Phone: 732-590-5000

Chairman and President of Daiichi Sankyo, Inc.

Glenn J. Gormley, M.D., Ph.D.

Acting President Daiichi Sankyo Administrative and Commercial Operations

Greg Barrett

Parent Company:

DAIICHI SANKYO, COMPANY, LTD. (TSE 4568)
3-5-1, Nihonbashi-honcho, Chuo-ku, Tokyo
103-8426, Japan
Phone: +81-3-6225-1111
daiichisankyo.com

European Headquarters:

DAIICHI SANKYO EUROPE, GhbH
Zielstattstrasse 48
81379 Munich, Germany
Phone: +49-89-7808-0
daiichi-sankyo.eu

Employees Worldwide:

31,929 employees (as of May 2012)

Products Marketed in the U.S.:

AZOR® (amlodipine/olmesartan medoxomil)
See full Prescribing Information including Boxed WARNING regarding Fetal Toxicity.


BENICAR® (olmesartan medoxomil)
See full Prescribing Information including Boxed WARNING regarding Fetal Toxicity.


BENICAR HCT® (olmesartan medoxomil/hydrocholorothiazide)
See full Prescribing Information including Boxed WARNING regarding Fetal Toxicity.


EFFIENT® (prasugrel) tablets
See full Prescribing Information including Boxed WARNING regarding Bleeding Risk.


EVOXAC® (cevimeline HCI)
See full Prescribing Information.


TRIBENZOR®
(olmesartan medoxomil/amlodipine/hydrocholorothiazide)
See full Prescribing Information including Boxed WARNING regarding Fetal Toxicity.


WELCHOL® (colesevelam HCI)
See full Prescribing Information.


ZELBORAF® (vemurafenib)
See full Prescribing Information.